Candriam Equities L Oncology Impact I/ LU1864482515 /
| NAV2024-07-25 | Chg.+11.5701 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 2,298.7400GBP | +0.51% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | - | - | - | 10.22 | 10.74 | 1.48 | -1.69 | 0.14 | 7.21 | -2.22 | 2.49 | 1.44 | - |
| 2021 | 0.09 | -5.90 | 1.24 | 1.97 | -2.18 | 6.26 | -1.59 | 6.66 | -1.78 | 1.68 | -2.99 | 1.57 | +4.39% |
| 2022 | -9.64 | -1.76 | 6.66 | -1.27 | -1.71 | 3.82 | 4.16 | 1.30 | -0.67 | 3.78 | 2.55 | -4.40 | +1.72% |
| 2023 | -0.19 | -2.26 | -0.73 | 1.15 | -1.18 | -2.43 | -0.31 | -0.51 | -1.63 | -5.81 | 4.68 | 5.01 | -4.59% |
| 2024 | 1.47 | 4.84 | 1.63 | -2.53 | 0.79 | 1.91 | 3.13 | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 10.69% | 10.65% | 11.02% | 14.40% | -% |
| Sharpe ratio | 1.68 | 1.74 | 0.88 | 0.06 | - |
| Best month | +5.01% | +4.84% | +5.01% | +6.66% | +10.74% |
| Worst month | -2.53% | -2.53% | -5.81% | -9.64% | -9.64% |
| Maximum loss | -4.95% | -4.95% | -8.80% | -18.83% | - |
| Outperformance | - | - | - | - | - |
All quotes in GBP
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Oncology Imp... | reinvestment | 2,491.8899 | +13.92% | +7.44% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,663.3601 | +14.06% | +7.84% | |
| Candriam Equities L Oncology Imp... | reinvestment | 214.5600 | +10.20% | -3.81% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,298.7400 | +13.38% | +14.24% | |
| Candriam Equities L Oncology Imp... | paying dividend | 1,671.3400 | +13.55% | +6.41% | |
| Candriam Equities L Oncology Imp... | reinvestment | 254.4800 | +14.45% | +12.52% | |
| Candriam Equities L Oncology Imp... | paying dividend | 244.6500 | +12.48% | +3.46% | |
| Candriam Equities L Oncology Imp... | paying dividend | 198.4200 | +13.45% | +6.10% | |
| Candriam Equities L Oncology Imp... | paying dividend | 21,262.0000 | +9.18% | +1.28% | |
| Candriam Equities L Oncology Imp... | reinvestment | 162.5900 | +13.25% | +13.85% | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,185.2700 | +11.24% | -1.06% | |
| Candriam Equities L Oncology Imp... | reinvestment | 270.0600 | +15.42% | +15.41% | |
| Candriam Equities L Oncology Imp... | reinvestment | 213.8700 | +9.76% | -4.95% | |
| Candriam Equities L Oncology Imp... | reinvestment | 297.5200 | +13.44% | +6.09% | |
| Candriam Equities L Oncology Imp... | reinvestment | 200.8000 | +11.19% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 1,897.1100 | +13.74% | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 2,991.6001 | +13.55% | +6.41% | |
| Candriam Equities L Oncology Imp... | reinvestment | 163.4700 | - | - | |
| Candriam Equities L Oncology Imp... | reinvestment | 284.2500 | +12.49% | +3.45% |
Performance
| YTD | +11.62% | ||
|---|---|---|---|
| 6 Months | +10.53% | ||
| 1 Year | +13.38% | ||
| 3 Years | +14.24% | ||
| 5 Years | - | ||
| 10 Years | - | ||
| Since start | +53.25% | ||
| Year | |||
| 2023 | -4.59% | ||
| 2022 | +1.72% | ||
| 2021 | +4.39% | ||
